IRVINE, CA / ACCESSWIRE / March 21, 2023 / Accurate Background, the world's largest privately held provider of compliant background checks, drug and health screening, and monitoring solutions, today ...
Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to ...
May 20, 2011 (San Diego, CA) — The platelet-function test VerifyNow P2Y12 (Accumetrics), has been granted a CE mark in Europe for a new, updated claim for prognostic use to help identify patients with ...
An omnipresent possibility, platelet resistance is being studied more closely as witnessed by the POPULAR study published during AHA. New tests such as "VerifyNow" offer us onsite methods to screen ...
Aspirin is a powerful and important medication in management of various cardiovascular diseases. Simply put, aspirin shuts down the platelets, a clot-producing cells, and mainly through this action ...
Even relatively mild anemia predicts high residual platelet reactivity following percutaneous coronary intervention (PCI) in patients pre-treated with clopidogrel, according to data published online ...
Our mission is to empower South African businesses to navigate the complexities of FICA compliance effortlessly” - Ru Foster - CEO Verify NowJOHANNESBURG, GAUTENG, SOUTH AFRICA, September 18, 2024 ...
The Next Step in Accurate's Leadership as a Global Screening Provider IRVINE, CA / ACCESSWIRE / March 21, 2023 / Accurate Background, the world's largest privately held provider of compliant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results